Katzmann Julius L, Mahfoud Felix, Böhm Michael, Schulz Martin, Laufs Ulrich
Department of Cardiology, Universitätsklinikum Leipzig, Leipzig, Germany,
Medical Clinic III, Cardiology, Angiology, Intensive Care, Universitätsklinikum des Saarlandes, Homburg, Germany.
Patient Prefer Adherence. 2018 Dec 18;13:9-19. doi: 10.2147/PPA.S182765. eCollection 2019.
Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence.
The aim of this study was to elucidate the associations between adherence to lipid-and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP.
This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart.
A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons <0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications.
Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care.
许多心血管疾病高危患者的低密度脂蛋白胆固醇(LDL-C)和血压(BP)未达目标值。抑郁症是这些患者常见的合并症,会导致药物依从性差。
本研究旨在阐明降脂和降压药物依从性、抑郁症诊断与LDL-C及血压控制之间的关联。
本研究在德国开展,为多中心、单次就诊的横断面研究。采用Morisky药物依从性量表-8(MMAS-8)评估依从性,通过患者病历记录评估抑郁症。
共纳入3188例门诊患者,其中高胆固醇血症患者占39.8%,稳定型冠状动脉疾病(CAD)患者占7.4%,两者兼具的患者占52.9%。患者有心肌梗死病史者占30.8%,糖尿病患者占42.0%,吸烟者占19.7%,16.1%的患者经研究者报告诊断为抑郁症。与低依从性相比,高或中度降脂药物依从性与较低的LDL-C水平(105.5±38.3 vs 120.8±42.4 mg/dL)、较低的血压(收缩压133.4±14.5 vs 137.9±13.9 mmHg,舒张压78.3±9.6 vs 81.8±9.6 mmHg)相关,且达到指南推荐的LDL-C目标(16.9% vs 10.1%)和血压目标(52.2% vs 40.8%,所有比较均<0.0001)的患者比例更高。抑郁症患者的依从性更差。相应地,抑郁症患者的LDL-C水平更高、血压更高,实现LDL-C和血压目标的概率更低。降压药和降脂药的药物依从性之间存在相关性。
在日常实践中可轻松获得自我报告的药物依从性。低依从性和抑郁症诊断可识别出LDL-C和血压未得到控制、可能从强化治疗中获益的高危患者。